In a groundbreaking development, Elon Musk's company Neuralink has received approval from the US Food and Drug Administration (FDA) to conduct the world's first human trials of brain implants. This exciting advancement brings us closer to witnessing a science fiction concept becoming a reality. Neuralink's technology involves implanting a chip in the human brain that can monitor brain activity and transmit the data to a computer. The company believes that this technology has the potential to treat a variety of conditions, including blindness, paralysis, and various degenerative diseases. While the recruitment process for Neuralink's clinical trial has not yet begun, the company's approval by the FDA is a significant milestone. It is a sign that the technology is moving closer to being available to patients, and it could have a major impact on the treatment of brain-related conditions. How does Neuralink work? Neuralink's technology is based on a system of t...
Artificial Intelligence Research | Quantum Communication | Space Research Missions | Medical Technology Innovations | Future Science NEWS